Antibodies against macrophages that overlap in specificity with fibroblasts

被引:116
作者
Inoue, T
Plieth, D
Venkov, CD
Xu, C
Neilson, EG
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
关键词
macrophage; fibroblast; FSP1; S100A4; F4/80; Mac-1; Mac-2; Mac-3; CD68; CD45;
D O I
10.1111/j.1523-1755.2005.00358.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Fibroblasts can be misidentifted as macrophages because both cell types share antigens that are associated with popular antibodies targeting the monocyte/ macrophage lineage. With the recent description of fibroblast-specific protein 1 (FSP1), we revisited the specificity of antibodies directed against macrophages to determine systematically which antibodies best distinguish both cell types in fibrotic tissues. Methods. Tissue fibrosis was produced in mice carrying the GFP transgene encoding green fluorescent protein under the control of the FSP1 promoter. Single cell suspensions from these marked tissues were submitted for flow cytometry using antibodies against Mac-1. Mac-2, Mac-3, F4/80, CD68, major histocompatibility complex (MHC) class II, and CD45, and cDNA amplification of mRNA encoding the above target antigens was performed using specific primer sets in sorted pools of cells. Fibrotic tissues were also stained by immunohistochemistry with the same antibodies and examined under confocal microscopy. Results. Comparison overlap between FSP1(+) fibroblasts with each of the macrophage markers demonstrated that all antimacrophage antibodies (Mac-1, Mac-2, Mac-3, CD68, MHC class II, and CD45) except one (F4/80) recognize both cell types. Conclusion. Antibodies directed against F4/80 clearly distinguish macrophages from FSP1(+) fibroblasts in fibrotic tissues and is the preferred antibody in mice.
引用
收藏
页码:2488 / 2493
页数:6
相关论文
共 28 条
[1]   Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites [J].
Abe, R ;
Donnelly, SC ;
Peng, T ;
Bucala, R ;
Metz, CN .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7556-7562
[2]   F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE [J].
AUSTYN, JM ;
GORDON, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) :805-815
[3]   TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia [J].
Bhowmick, NA ;
Chytil, A ;
Plieth, D ;
Gorska, AE ;
Dumont, N ;
Shappell, S ;
Washington, MK ;
Neilson, EG ;
Moses, HL .
SCIENCE, 2004, 303 (5659) :848-851
[4]  
FLOTTE TJ, 1983, AM J PATHOL, V111, P112
[5]   MODULATION OF MTS1 EXPRESSION IN MOUSE AND HUMAN NORMAL AND TUMOR-CELLS [J].
GRIGORIAN, M ;
TULCHINSKY, E ;
BURRONE, O ;
TARABYKINA, S ;
GEORGIEV, G ;
LUKANIDIN, E .
ELECTROPHORESIS, 1994, 15 (3-4) :463-468
[6]   Pluripotent stem cells identified in multiple murine tissues [J].
Howell, JC ;
Lee, WH ;
Morrison, P ;
Zhong, J ;
Yoder, MC ;
Srour, EF .
HEMATOPOIETIC STEM CELLS 2002: GENETICS AND FUNCTION, 2003, 996 :158-173
[7]   Evidence that fibroblasts derive from epithelium during tissue fibrosis [J].
Iwano, M ;
Plieth, D ;
Danoff, TM ;
Xue, C ;
Okada, H ;
Neilson, EG .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (03) :341-350
[8]   Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts [J].
Iwano, M ;
Fischer, A ;
Okada, H ;
Plieth, D ;
Xue, CS ;
Danoff, TM ;
Neilson, EG .
MOLECULAR THERAPY, 2001, 3 (02) :149-159
[9]   Epithelial-mesenchymal transition and its implications for fibrosis [J].
Kalluri, R ;
Neilson, EG .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (12) :1776-1784
[10]  
Klingelhofer J, 1997, DEV DYNAM, V210, P87, DOI 10.1002/(SICI)1097-0177(199710)210:2<87::AID-AJA2>3.0.CO